These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 35656988)
1. Validation of the WATCH-DM and TRS-HF Segar MW; Patel KV; Hellkamp AS; Vaduganathan M; Lokhnygina Y; Green JB; Wan SH; Kolkailah AA; Holman RR; Peterson ED; Kannan V; Willett DL; McGuire DK; Pandey A J Am Heart Assoc; 2022 Jun; 11(11):e024094. PubMed ID: 35656988 [TBL] [Abstract][Full Text] [Related]
2. Prediction of heart failure outcomes in patients with type 2 diabetes mellitus: Validation of the Thrombolysis in Myocardial Infarction Risk Score for Heart Failure in Diabetes (TRS-HF Elharram M; Ferreira JP; Huynh T; Ni J; Giannetti N; Verma S; Zannad F; Sharma A Diabetes Obes Metab; 2021 Mar; 23(3):782-790. PubMed ID: 33269511 [TBL] [Abstract][Full Text] [Related]
3. Incorporation of natriuretic peptides with clinical risk scores to predict heart failure among individuals with dysglycaemia. Segar MW; Khan MS; Patel KV; Vaduganathan M; Kannan V; Willett D; Peterson E; Tang WHW; Butler J; Everett BM; Fonarow GC; Wang TJ; McGuire DK; Pandey A Eur J Heart Fail; 2022 Jan; 24(1):169-180. PubMed ID: 34730265 [TBL] [Abstract][Full Text] [Related]
4. Effect of Canagliflozin on Heart Failure Hospitalization in Diabetes According to Baseline Heart Failure Risk. Khan MS; Segar MW; Usman MS; Patel KV; Van Spall HGC; DeVore AD; Vaduganathan M; Lam CSP; Zannad F; Verma S; Butler J; Tang WHW; Pandey A JACC Heart Fail; 2023 Jul; 11(7):825-835. PubMed ID: 37227388 [TBL] [Abstract][Full Text] [Related]
5. Machine Learning to Predict the Risk of Incident Heart Failure Hospitalization Among Patients With Diabetes: The WATCH-DM Risk Score. Segar MW; Vaduganathan M; Patel KV; McGuire DK; Butler J; Fonarow GC; Basit M; Kannan V; Grodin JL; Everett B; Willett D; Berry J; Pandey A Diabetes Care; 2019 Dec; 42(12):2298-2306. PubMed ID: 31519694 [TBL] [Abstract][Full Text] [Related]
6. External validation and extension of the TIMI risk score for heart failure in diabetes for patients with recent acute coronary syndrome: An analysis of the EXAMINE trial. Razaghizad A; Sharma A; Ni J; Ferreira JP; White WB; Mehta CR; Bakris GL; Zannad F Diabetes Obes Metab; 2023 Jan; 25(1):229-237. PubMed ID: 36082521 [TBL] [Abstract][Full Text] [Related]
7. Predicting incident heart failure among patients with type 2 diabetes mellitus: The DM-CURE risk score. Lin Y; Shao H; Shi L; Anderson AH; Fonseca V Diabetes Obes Metab; 2022 Nov; 24(11):2203-2211. PubMed ID: 35801340 [TBL] [Abstract][Full Text] [Related]
8. Impact of Residential Social Deprivation on Prediction of Heart Failure in Patients With Type 2 Diabetes: External Validation and Recalibration of the WATCH-DM Score Using Real World Data. Deo SV; Al-Kindi S; Motairek I; McAllister D; Shah ASV; Elgudin YE; Gorodeski EZ; Virani S; Petrie MC; Rajagopalan S; Sattar N Circ Cardiovasc Qual Outcomes; 2024 Mar; 17(3):e010166. PubMed ID: 38328913 [TBL] [Abstract][Full Text] [Related]
9. Empagliflozin reduces the risk of mortality and hospitalization for heart failure across Thrombolysis In Myocardial Infarction Risk Score for Heart Failure in Diabetes categories: Post hoc analysis of the EMPA-REG OUTCOME trial. Verma S; Sharma A; Zinman B; Ofstad AP; Fitchett D; Brueckmann M; Wanner C; Zwiener I; George JT; Inzucchi SE; Butler J; Mazer CD Diabetes Obes Metab; 2020 Jul; 22(7):1141-1150. PubMed ID: 32227432 [TBL] [Abstract][Full Text] [Related]
10. Development and Validation of Machine Learning-Based Race-Specific Models to Predict 10-Year Risk of Heart Failure: A Multicohort Analysis. Segar MW; Jaeger BC; Patel KV; Nambi V; Ndumele CE; Correa A; Butler J; Chandra A; Ayers C; Rao S; Lewis AA; Raffield LM; Rodriguez CJ; Michos ED; Ballantyne CM; Hall ME; Mentz RJ; de Lemos JA; Pandey A Circulation; 2021 Jun; 143(24):2370-2383. PubMed ID: 33845593 [TBL] [Abstract][Full Text] [Related]
11. Ten-Year Risk-Prediction Equations for Incident Heart Failure Hospitalizations in Chronic Kidney Disease: Findings from the Chronic Renal Insufficiency Cohort Study and the Multi-Ethnic Study of Atherosclerosis. Mehta R; Ning H; Bansal N; Cohen J; Srivastava A; Dobre M; Michos ED; Rahman M; Townsend R; Seliger S; Lash JP; Isakova T; Lloyd-Jones DM; Khan SS J Card Fail; 2022 Apr; 28(4):540-550. PubMed ID: 34763078 [TBL] [Abstract][Full Text] [Related]
12. Adaptation of risk prediction equations for cardiovascular outcomes among patients with type 2 diabetes in real-world settings: a cross-institutional study using common data model approach. Yang CT; Chong KS; Wang CC; Ou HT; Kuo S Cardiovasc Diabetol; 2024 Jul; 23(1):244. PubMed ID: 38987773 [TBL] [Abstract][Full Text] [Related]
13. Development and validation of a model to predict cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke in patients with type 2 diabetes mellitus and established atherosclerotic cardiovascular disease. Stevens SR; Segar MW; Pandey A; Lokhnygina Y; Green JB; McGuire DK; Standl E; Peterson ED; Holman RR Cardiovasc Diabetol; 2022 Aug; 21(1):166. PubMed ID: 36030198 [TBL] [Abstract][Full Text] [Related]
14. WATCH-DM risk score predicts the prognosis of diabetic phenotype patients with heart failure and preserved ejection fraction. Zhang X; Lv X; Wang N; Yu S; Si J; Zhang Y; Cai M; Liu Y Int J Cardiol; 2023 Aug; 385():34-40. PubMed ID: 37257517 [TBL] [Abstract][Full Text] [Related]
15. Association of Baseline and Longitudinal Changes in Body Composition Measures With Risk of Heart Failure and Myocardial Infarction in Type 2 Diabetes: Findings From the Look AHEAD Trial. Patel KV; Bahnson JL; Gaussoin SA; Johnson KC; Pi-Sunyer X; White U; Olson KL; Bertoni AG; Kitzman DW; Berry JD; Pandey A; Circulation; 2020 Dec; 142(25):2420-2430. PubMed ID: 33164570 [TBL] [Abstract][Full Text] [Related]
16. Prognostic models for heart failure in patients with type 2 diabetes: a systematic review and meta-analysis. Kostopoulos G; Doundoulakis I; Toulis KA; Karagiannis T; Tsapas A; Haidich AB Heart; 2023 Sep; 109(19):1436-1442. PubMed ID: 36898704 [TBL] [Abstract][Full Text] [Related]
17. Association of Intensive Lifestyle Intervention, Fitness, and Body Mass Index With Risk of Heart Failure in Overweight or Obese Adults With Type 2 Diabetes Mellitus: An Analysis From the Look AHEAD Trial. Pandey A; Patel KV; Bahnson JL; Gaussoin SA; Martin CK; Balasubramanyam A; Johnson KC; McGuire DK; Bertoni AG; Kitzman D; Berry JD; Circulation; 2020 Apr; 141(16):1295-1306. PubMed ID: 32134326 [TBL] [Abstract][Full Text] [Related]
18. Optimal cardiometabolic health and risk of heart failure in type 2 diabetes: an analysis from the Look AHEAD trial. Patel KV; Khan MS; Segar MW; Bahnson JL; Garcia KR; Clark JM; Balasubramanyam A; Bertoni AG; Vaduganathan M; Farkouh ME; Januzzi JL; Verma S; Espeland M; Pandey A Eur J Heart Fail; 2022 Nov; 24(11):2037-2047. PubMed ID: 36280384 [TBL] [Abstract][Full Text] [Related]
19. Heart Failure Risk Stratification and Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes Mellitus. Berg DD; Wiviott SD; Scirica BM; Gurmu Y; Mosenzon O; Murphy SA; Bhatt DL; Leiter LA; McGuire DK; Wilding JPH; Johanson P; Johansson PA; Langkilde AM; Raz I; Braunwald E; Sabatine MS Circulation; 2019 Nov; 140(19):1569-1577. PubMed ID: 31474116 [TBL] [Abstract][Full Text] [Related]
20. Glycemic status and incident heart failure in elderly without history of diabetes mellitus: the health, aging, and body composition study. Kalogeropoulos A; Georgiopoulou V; Harris TB; Kritchevsky SB; Bauer DC; Smith AL; Strotmeyer E; Newman AB; Wilson PW; Psaty BM; Butler J; J Card Fail; 2009 Sep; 15(7):593-9. PubMed ID: 19700136 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]